AAN17: Study demonstrates cannabis-based medicine may reduce epileptic seizures

Written by Frances Adlam, Future Science Group

A collaborative group of researchers from the Nationwide Children’s Hospital and the Ohio State University College of Medicine (both OH, USA) have demonstrated the therapeutic effect of cannabidiol in reducing seizures in children and adults suffering from Lennox- Gastaut syndrome (LGS). The results, which will be presented at the American the American Academy of Neurology’s 69th Annual Meeting (held 22–28 April 2017, NY, USA), provide a possible treatment for drop seizures, a type of epilepsy that is notoriously challenging to treat. LGS is a severe form of epilepsy, developed in childhood, that leads patients to suffer from multiple forms of...

To view the full article, please register now for access

It's completely free